What medications are contraindicated with dimenhydrinate (Dramamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications Contraindicated with Dimenhydrinate

Dimenhydrinate is contraindicated with medications that may cause additive central nervous system depression, anticholinergic effects, or ototoxicity masking, including alcohol, other CNS depressants, anticholinergic drugs, and certain antibiotics.

Mechanism of Action and Composition

Dimenhydrinate (Dramamine) is composed of diphenhydramine and 8-chlorotheophylline. Its primary mechanism of action is H1-histamine receptor antagonism, with significant anticholinergic properties 1. Understanding this helps explain the potential drug interactions.

Specific Contraindications and Drug Interactions

1. CNS Depressants

  • Alcohol and other CNS depressants: Concomitant use can have an additive sedative effect, significantly impairing mental and physical abilities 1
  • Benzodiazepines: May enhance CNS depression, increasing risk of excessive sedation
  • Opioids: Combined use may increase risk of sedation and respiratory depression

2. Anticholinergic Medications

  • Other antihistamines: Additive anticholinergic effects
  • Tricyclic antidepressants: Increased risk of anticholinergic side effects
  • Antipsychotics: May enhance anticholinergic effects and increase risk of adverse reactions

3. Medications with Ototoxic Potential

  • Certain antibiotics: Dimenhydrinate can mask symptoms of ototoxicity from antibiotics, potentially allowing progression to irreversible damage 1

4. Cardiac Medications

  • Class I and Class III antiarrhythmics: Increased risk of QT prolongation
  • Amiodarone, flecainide, propafenone, quinidine: Contraindicated due to risk of cardiac arrhythmias 2

5. Other Important Interactions

  • Monoamine oxidase inhibitors (MAOIs): Can potentiate anticholinergic effects 2
  • CYP3A inhibitors or inducers: May affect metabolism of dimenhydrinate
  • Drugs with narrow therapeutic indices: Caution due to potential for altered metabolism

Special Populations and Considerations

Pediatric Patients

  • Dimenhydrinate should be used with caution in children due to risk of paradoxical excitation 1
  • Contraindicated in neonates due to benzyl alcohol content in some formulations 1

Elderly Patients

  • Increased risk of dizziness and falls in elderly patients 3
  • Second-generation antihistamines may be safer alternatives 3

Patients with Specific Conditions

Dimenhydrinate should be used with caution in patients with:

  • Prostatic hypertrophy
  • Stenosing peptic ulcer
  • Pyloroduodenal obstruction
  • Bladder neck obstruction
  • Narrow-angle glaucoma
  • Bronchial asthma
  • Cardiac arrhythmias 1

Overdose Risk and Abuse Potential

Dimenhydrinate has abuse potential due to its ability to cause euphoria, hallucinations, and anxiolytic effects in high doses 4, 5. This risk increases when combined with other substances. Severe overdose can lead to status epilepticus, ventricular dysrhythmias, and potentially death 6.

Clinical Recommendations

  • Always obtain a complete medication history before prescribing dimenhydrinate
  • Consider alternative antiemetics in patients taking contraindicated medications
  • Second-generation antihistamines may be preferable for patients at risk of CNS effects 3
  • Monitor patients on multiple medications for signs of excessive sedation or anticholinergic effects
  • Educate patients about avoiding alcohol and other CNS depressants while taking dimenhydrinate

By carefully screening for contraindications and monitoring for potential drug interactions, clinicians can minimize the risk of adverse effects associated with dimenhydrinate use.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diphenhydramine-Induced Dizziness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mechanisms and abuse liability of the anti-histamine dimenhydrinate.

Neuroscience and biobehavioral reviews, 2002

Research

Fatality secondary to massive overdose of dimenhydrinate.

Annals of emergency medicine, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.